1Janka G. Hemophagoeytic lymphohistiocytosis: when the immune system runs amok [J]. Kiln Padiatr, 2009, 221 (5) : 278-285.
2Henter J-I, Arico M, Elinder G, el al. Familial hemophagocytic lymphohistiocytosis (primary HLH) [J]. Hematol Oncol Clin North Am, 1998,12:417- 433.
3Janka G, zur Stadt U. Familial hemophagocytic lymphohistiocytosis [J ]. Hematol Am Soc Hematol Educ Program, 2005, 82- 88.
4Henter J-I, Samuelsson AC, Arico M, et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemo- therapy and bone marrow transplantation [J ]. Blood, 2002, 100: 2367-2373.
5Imashuku S. Clinical features and treatment strategies of Epstein- Barr virus-associated hemophagocytic lymphohistiocytosis [J].Crit Rev Oncol Hematol,2002,44: 259-272.
6Ishii E, Ohga S, Imashuku S, et al. Review of hemophagocytic lymphohistiocytosis (HLH) in children with focus on Japanese experiences[J ]. Crit Rev Oncol tlematol, 2005,53 : 209-223.
7Schaer D J, Schleiffenbaum R. Kurrar M. et al. Soluble hemoglobin- haptoglobin scavenger receptor CD 163 as a lineage-specific marker in the reactive hemophagocytic syndrome[J ]. Eur J Haematol, 2005,74( 1 ) :6-10.
8Caslillo L, Carc:ilia J. Secondary HLH and severe sepsis/SIRS/ MODS/MAS share common intermediate phenotypes on a spectrum of inflammalion [J].Pediatr Crit Care Med, 2009, 10 ( 3 ) : 387-392.
9Imashuku S. Systemic typc Epstein-Barr virus-related lymphoproliferative diseases in children and young adults: challenges for pediatric hemato-oncologists and infectious disease specialists[J]. Pediatr Hematol Oncol, 2007,24(8) : 563-568.
10Moretta A, Bottino C, Vitale M, et al. Activating receptors and coreceplors involved in human natural killer cell-mediated cytolysis[J]. A nnu Rev Immunol, 2001,19 : 197-223.
二级参考文献18
1Ishiia E, Ohgab S,Imashukuc S, et al. Review of hemophagocytic lymphohistiocytosis (HLH) in children with focus on Japanese experiences . Oncology/Hematology, 2005,53(3) : 209-223.
2Heater JI, Home A,Arico M,et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis . Pediatr Brood Cancer, 2007,48(2) : 124-131.
4Creput C, Galicier L, Buyse S, et al. Understanding organ dysfunction in hemophagocytic lymphohistiocytosis. Intensive Care Med, 2008, 34 (7) : 1177-1187.
5Kobasa D, Jones SM, Shinya K, et al. Aberrant innate response in lethal infection of macaques with the 1918 influenza virus . Nature, 2007, 445 (7125) : 319-323.
6De Jong MD, Simmons CP, Thanh Tr, et al. Fatal outcome of human influenza A (HSN1) is associated with high viral load and hypercytokinemia . Nature Med,2006,12(10) : 1203-1207.
7Schaer DJ, Schaer CA, Schoedon G, et al. Hemophagocytic macrophages constitute a major compartment of hemeoxygenase expression in sepsis. Eur J Haematol,2006,77(5) :432-436.
9Zur Stadt U, Beutel K, Kolherg S, et al. Mutation spectrum in children with primary hemophagocytic lymphohistiocytosis: molecular and functional analyses of PRF1, UNC13D, STX11, and RAB27A. Hum Murat, 2006,27 (1):62-68.
10Zur Stadt U,Schmidt S, Kasper B,et al.Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q2A and identification of mutations in syntaxin 11. Hum Mol Genet,2005,14(6):827-834.
